Accesso libero

Staphylococcal Toxic Shock Syndrome Caused By An Intravaginal Product. A Case Report

  
09 feb 2016
INFORMAZIONI SU QUESTO ARTICOLO

Cita
Scarica la copertina

1. De Rosa FG, Corcione S, Motta I, et al. Risk factors for mortality in patients with Staphylococcus aureus bloodstream infection. J Chemother. 2015:1973947815Y0000000076. [Epub ahead of print]Search in Google Scholar

2. Klug CD, Keay CR, Ginde AA. Fatal toxic shock syndrome from an intrauterine device. Ann Emerg Med. 2009;54:701-3.10.1016/j.annemergmed.2009.05.030Search in Google Scholar

3. David M, Daum R. Community-Associated Methicillin- Resistant Staphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic. Clin Microbiol Rev. 2010;23:616-87.10.1128/CMR.00081-09Search in Google Scholar

4. Stingley RL, Liu H, Mullis LB, Elkins CA, Hart ME. Staphylococcus aureus toxic shock syndrome toxin-1 (TSST-1) production and Lactobacillus species growth in a defined medium simulating vaginal secretions. J Microbiol Methods. 2014;106:57-66.10.1016/j.mimet.2014.08.002Search in Google Scholar

5. Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev. 1997;10:505-20.10.1128/CMR.10.3.505Search in Google Scholar

6. Diawara I, Bekhti K, Elhabchi D, et al. Staphylococcus aureus nasal carriage in hemodialysis centers of Fez, Morocco. Iran J Microbiol. 2014;6:175-83.Search in Google Scholar

7. Todd J, Fishaut M, Kapral F, Welch T. Toxic-shock syndrome associated with phage-group-I Staphylococci. Lancet. 1978;2:1116-8.10.1016/S0140-6736(78)92274-2Search in Google Scholar

8. Chan Y, Selvaratnam V, Garg N. Toxic shock syndrome post open reduction and Kirschner wire fixation of a humeral lateral condyle fracture. BMJ Case Rep. 2015;2015. pii: bcr2015210090.10.1136/bcr-2015-210090453362726264942Search in Google Scholar

9. Jiang W, Zhou Z, Zhang K, Yu Y. Epidemiological investigation of community-acquired Staphylococcus aureus infection. Genet Mol Res. 2013;12:6923-30.10.4238/2013.December.19.1124391040Search in Google Scholar

10. Ono HK, Sato’o Y, Narita K, et al. Identification and Characterization of a Novel Staphylococcal Emetic Toxin. Appl Environ Microbiol. 2015;81:7034-40.10.1128/AEM.01873-15457945926231643Search in Google Scholar

11. Le Moing V, Alla F, Doco-Lecompte T, et al. Staphylococcus aureus Bloodstream Infection and Endocarditis - A Prospective Cohort Study. PLoS One. 2015;10:e0127385.10.1371/journal.pone.0127385444745226020939Search in Google Scholar

12. Paulsen J, Mehl A, A, Solligard E, Asvold BO, Damas JK. Epidemiology and outcome of Staphylococcus aureus bloodstream infection and sepsis in a Norwegian county 1996-2011: an observational study. BMC Infect Dis. 2015;15:116.10.1186/s12879-015-0849-4435168125887177Search in Google Scholar

13. Ekpe K, Novara A, Mainardi JL, Fagon JY, Faisy C. Methicillinresistant Staphylococcus aureus bloodstream infections are associated with a higher energy deficit than other ICU-acquired bacteremia. Intensive Care Med. 2014;40:1878-87.10.1007/s00134-014-3502-625288210Search in Google Scholar

14. Mitchell MA, Bisch S, Arntfield S, Hosseini-Moghaddam SM. A confirmed case of toxic shock syndrome associated with the use of a menstrual cup. Can J Infect Dis Med Microbiol. 2015;26:218-20.10.1155/2015/560959455618426361491Search in Google Scholar

15. Lachant DJ, Apostolakos M, Pietropaoli A. Methicillin Resistant Staphylococcus aureus Prostatic Abscess with Bacteremia. Case Rep Infect Dis. 2013;2013:613961.Search in Google Scholar

16. Honarpisheh H, Camp R, Lazova R. Staphylococcal Purpura Fulminans: Report of a Case. Am J Dermatopathol. 2015;37:643-6.10.1097/DAD.000000000000017525099358Search in Google Scholar

17. El Zakhem A, Chaftari AM, Bahu R, et al. Central line-associated bloodstream infections caused by Staphylococcus aureus in cancer patients: Clinical outcome and management. Ann Med. 2014;46:163-8.10.3109/07853890.2013.87851324491173Search in Google Scholar

18. Dinges MM, Orwin P, Schlievert P. Exotoxins of Staphyloccocus aureus. Clin Microbiol Rev. 2000;13:16-34.10.1128/CMR.13.1.168893110627489Search in Google Scholar

19. Tilahun AY, Karau M, Ballard A, et al. The impact of Staphylococcus aureus-associated molecular patterns on staphylococcal superantigen-induced toxic shock syndrome and pneumonia. Mediators Inflamm. 2014;2014:468285.10.1155/2014/468285408293025024509Search in Google Scholar

20. Low DE. Toxic shock syndrome: major advances in pathogenesis, but not treatment. Crit Care Clin. 2013;29:651-75.10.1016/j.ccc.2013.03.01223830657Search in Google Scholar

21. DeVries AS, Lesher L, Schlievert PM, et al. Staphylococcal toxic shock syndrome 2000-2006: epidemiology, clinical features, and molecular characteristics. PLoS One. 2011;6:e22997.10.1371/journal.pone.0022997315791021860665Search in Google Scholar